|
|
| | 5-Quinoxalinecarbonitrile, 6-[[3-methoxy-4-[(6-methyl-3-pyridinyl)methoxy]phenyl]amino]-3-(4-morpholinyl)- Basic information |
| | 5-Quinoxalinecarbonitrile, 6-[[3-methoxy-4-[(6-methyl-3-pyridinyl)methoxy]phenyl]amino]-3-(4-morpholinyl)- Chemical Properties |
| Boiling point | 703.2±60.0 °C(Predicted) | | density | 1.35±0.1 g/cm3(Predicted) | | pka | 5.28±0.10(Predicted) | | form | Solid | | color | Light yellow to green yellow |
| | 5-Quinoxalinecarbonitrile, 6-[[3-methoxy-4-[(6-methyl-3-pyridinyl)methoxy]phenyl]amino]-3-(4-morpholinyl)- Usage And Synthesis |
| Uses | Enrupatinib is a colony-stimulating factor 1 receptor (CSF1R) inhibitor with antitumor activity[1]. | | References | [1] International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 38, No. 2, 2024. |
| | 5-Quinoxalinecarbonitrile, 6-[[3-methoxy-4-[(6-methyl-3-pyridinyl)methoxy]phenyl]amino]-3-(4-morpholinyl)- Preparation Products And Raw materials |
|